VAERS reports by lot

GSK Hepatitis A lot 3J9G4: VAERS reports

44 VAERS reports list lot 3J9G4 as a GSK Hepatitis A vaccine, received between 2023-01-24 and 2024-11-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
44
Reports
2%
Marked serious
0
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1534%
General / Systemic (non-local)920%
Dermatological (non-injection-site)511%
Cardiac / Cardiovascular49%
Gastrointestinal37%
Injection-site / Local reaction37%
Respiratory25%
Musculoskeletal25%
Allergic / Anaphylactic12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida9
California6
Texas5
New York3
Louisiana3
Ohio2
Georgia2
North Carolina2
Virginia1
Michigan1
Missouri1
Arizona1

Reports by month received

2023-011
2023-024
2023-033
2023-043
2023-051
2023-062
2023-073
2023-084
2023-122
2024-029
2024-041
2024-052
2024-063
2024-081
2024-091
2024-103
2024-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.